RxDoctor Payments Data

Teresa Chan-Leveno, MD

Otolaryngology · Dallas, TXNPI 1285806190

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,348 of the $1,848 with a category attached, or 72.9%. Inspire Medical Systems, Inc. accounts for 87.1% of it on its own, with 4 other manufacturers making up the rest. That places this record below the midpoint for otolaryngology clinicians in TX, where the typical reported total is $1,798.

$1,848in general payments, 2019–2025

Across 15 payments — averaging $123.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$2K
  • Atos Medical Inc$112
  • Cook Medical LLC$72
  • Medtronic$30
  • Alk-abello, Inc$25
$111,673in research payments, 2019–2025

Across 36 payments — averaging $3102.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Inspire Medical Systems, Inc.$112K

What the payments were for

  • Speaking & faculty fees$50027%
  • Food & beverage$1,34873%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Inspire Medical Systems, Inc.11$1,609
Atos Medical Inc1$112
Cook Medical LLC1$72
Medtronic1$30
Alk-abello, Inc1$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,848 in reported general payments places this provider in the 50th percentile of 729 otolaryngology providers in Texas.

See all otolaryngology providers in Texas

Medicare billing

Part B allowed, 2024
$61,375
Medicare patients
163
Services billed
363

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Olopatadine Hcl14$1,247
Famotidine71$684
Azelastine Hcl17$626
Ipratropium Bromide18$334
Fluticasone Propionate29$321
Omeprazole18$304
Pantoprazole Sodium42$258
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid13$216
Montelukast Sodium13$140

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →